HK1201724A1 - Cancer stem cell-targeted cancer therapy - Google Patents
Cancer stem cell-targeted cancer therapyInfo
- Publication number
- HK1201724A1 HK1201724A1 HK15102215.8A HK15102215A HK1201724A1 HK 1201724 A1 HK1201724 A1 HK 1201724A1 HK 15102215 A HK15102215 A HK 15102215A HK 1201724 A1 HK1201724 A1 HK 1201724A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cancer
- stem cell
- targeted
- therapy
- cancer therapy
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000011275 oncology therapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84343106P | 2006-09-07 | 2006-09-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1201724A1 true HK1201724A1 (en) | 2015-09-11 |
Family
ID=39157850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15102215.8A HK1201724A1 (en) | 2006-09-07 | 2015-03-04 | Cancer stem cell-targeted cancer therapy |
Country Status (5)
Country | Link |
---|---|
US (3) | US20080118518A1 (fr) |
EP (2) | EP2783700A1 (fr) |
CA (1) | CA2698583A1 (fr) |
HK (1) | HK1201724A1 (fr) |
WO (1) | WO2008030538A2 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8394580B2 (en) * | 2007-08-17 | 2013-03-12 | The Johns Hopkins University | Protein markers for the detection of thyroid cancer metastasis |
WO2009064789A2 (fr) * | 2007-11-15 | 2009-05-22 | The Johns Hopkins University | Méthodes de détection et de surveillance de cellules souches cancéreuses circulantes |
US8663210B2 (en) | 2009-05-13 | 2014-03-04 | Novian Health, Inc. | Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy |
CA2800488A1 (fr) | 2010-05-26 | 2011-12-01 | Regents Of The University Of Minnesota | Anticorps anti-cd133 a fragment variable a chaine simple et ses utilisations |
US9945842B2 (en) | 2010-09-03 | 2018-04-17 | Abbvie Stemcentrx Llc | Identification and enrichment of cell subpopulations |
US9778264B2 (en) | 2010-09-03 | 2017-10-03 | Abbvie Stemcentrx Llc | Identification and enrichment of cell subpopulations |
PL2777398T3 (pl) * | 2010-11-23 | 2017-09-29 | The Rogosin Institute, Inc. | Sposób izolowania opornych na środek chemioterapeutyczny komórek rakowych o właściwościach komórek macierzystych |
WO2013119809A1 (fr) * | 2012-02-09 | 2013-08-15 | Georgia Health Sciences University Research Institute, Inc. | Biomarqueurs pour cancers hématologiques |
CA3223380A1 (fr) * | 2012-03-19 | 2013-09-26 | Stemline Therapeutics, Inc. | Methodes de traitement et de surveillance de l'etat du cancer |
LT3536334T (lt) | 2012-05-16 | 2021-10-11 | Stemline Therapeutics Inc. | Vakcina nuo vėžio, nukreipta į vėžines kamienines ląsteles |
US9778263B2 (en) | 2013-11-13 | 2017-10-03 | General Electric Company | Quantitative in situ characterization of biological samples |
EP3188840A1 (fr) | 2014-09-07 | 2017-07-12 | Selexis S.A. | Procédés et cartouches microfluidiques permettant la séparation de cellules |
DE202015009627U1 (de) | 2014-11-07 | 2018-11-15 | Akten-Ex Gmbh & Co. Kg | Papier aus einer Aktenvernichtung |
WO2017216791A1 (fr) * | 2016-06-13 | 2017-12-21 | Ariel Scientific Innovations Ltd. | Conjugués de médicaments anticancéreux |
WO2019067491A1 (fr) * | 2017-09-29 | 2019-04-04 | Oncocyclist, Inc. | Composition et méthode pour traiter la prolifération cellulaire |
EP3880216A4 (fr) * | 2018-11-16 | 2022-08-10 | Rapa Therapeutics, LLC | Méthodes de traitement d'un cancer avec des lymphocytes t fabriqués |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894326A (en) * | 1986-04-09 | 1990-01-16 | Fred Hutchinson Cancer Research Center | Monoclonal antibody defining oncofetal structure of fibronectin |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5169835A (en) * | 1989-01-18 | 1992-12-08 | Oklahoma Medical Research Foundation | Pregancy specific proteins applications |
US5300500A (en) * | 1989-02-23 | 1994-04-05 | The University Of North Carolina At Chapel Hill | 4 beta-amino podophyllotoxin analog compounds and methods |
US5980896A (en) * | 1989-06-30 | 1999-11-09 | Bristol-Myers Squibb Company | Antibodies reactive with human carcinomas |
AU659083B2 (en) * | 1989-12-14 | 1995-05-11 | Sloan-Kettering Institute For Cancer Research | Therapeutic uses of the hypervariable region of monoclonal antibody M195 and constructs thereof |
ATE169031T1 (de) * | 1991-04-05 | 1998-08-15 | Univ Washington | Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor |
DE4121547A1 (de) | 1991-06-28 | 1993-01-14 | Daimler Benz Ag | Mehrschichtisolierfolie |
GB9120467D0 (en) * | 1991-09-26 | 1991-11-06 | Celltech Ltd | Anti-hmfg antibodies and process for their production |
US6162432A (en) | 1991-10-07 | 2000-12-19 | Biogen, Inc. | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
US5441050A (en) | 1992-12-18 | 1995-08-15 | Neoprobe Corporation | Radiation responsive surgical instrument |
DE19600589C1 (de) * | 1996-01-10 | 1997-01-16 | Univ Eberhard Karls | Antikörper A3C6E2 |
US5843633A (en) * | 1996-04-26 | 1998-12-01 | Amcell Corporation | Characterization of a human hematopoietic progenitor cell antigen |
US5990281A (en) * | 1996-09-30 | 1999-11-23 | Genentech, Inc. | Vertebrate smoothened proteins |
US5942602A (en) * | 1997-02-13 | 1999-08-24 | Schering Aktiengessellschaft | Growth factor receptor antibodies |
US6541212B2 (en) * | 1997-03-10 | 2003-04-01 | The Regents Of The University Of California | Methods for detecting prostate stem cell antigen protein |
US6258939B1 (en) * | 1997-03-10 | 2001-07-10 | The Regents Of The University Of California | PSCA antibodies and hybridomas producing them |
US7361336B1 (en) * | 1997-09-18 | 2008-04-22 | Ivan Bergstein | Methods of cancer therapy targeted against a cancer stem line |
US6004528A (en) | 1997-09-18 | 1999-12-21 | Bergstein; Ivan | Methods of cancer diagnosis and therapy targeted against the cancer stemline |
US20040110822A1 (en) | 1998-07-14 | 2004-06-10 | The University Of Newcastle Research Associates | Anhydride modified cantharidin analogues useful in the treatment of cancer |
US7740841B1 (en) * | 2000-01-28 | 2010-06-22 | Sunnybrook Health Science Center | Therapeutic method for reducing angiogenesis |
ATE510855T1 (de) | 2000-03-06 | 2011-06-15 | Univ Kentucky Res Found | Verwendung eines antikörpers oder eines immunotoxins, der bzw. das selektiv an cd123 bindet zur beeinträchtigung hämatologischer krebs-vorläuferzellen |
US6632620B1 (en) * | 2000-06-22 | 2003-10-14 | Andrew N. Makarovskiy | Compositions for identification and isolation of stem cells |
US6984522B2 (en) * | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
AU2002250236A1 (en) | 2001-03-02 | 2002-09-19 | Medimmune, Inc. | Cd2 antagonists for treatment of autoimmune or inflammatory disease |
AUPR392301A0 (en) | 2001-03-23 | 2001-04-26 | University Of Newcastle Research Associates Limited, The | Protein phosphatase inhibitors |
US7666414B2 (en) * | 2001-06-01 | 2010-02-23 | Cornell Research Foundation, Inc. | Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen |
US6993175B2 (en) | 2001-09-07 | 2006-01-31 | Quest Diagnostics Investments Incorporated | Methods for measuring microvascular density in tumors |
JP2005511754A (ja) * | 2001-12-07 | 2005-04-28 | リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 乳癌幹細胞の予測的同定および特徴づけ |
EP2316487B1 (fr) * | 2003-04-11 | 2014-06-11 | MedImmune, LLC | Anticorps IL-9 recombinants et leurs utilisations |
US6773743B1 (en) * | 2003-06-02 | 2004-08-10 | Michael Andrew Singer | Low carbohydrate sweetener |
EP1532984A1 (fr) * | 2003-11-19 | 2005-05-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Utilisation d'anticorps anti-CD44 pour l'éradication des cellules souches de la leucémie myéloide aigue |
WO2007037782A2 (fr) * | 2005-02-08 | 2007-04-05 | The University Of North Carolina At Chapel Hill | Methode de traitement de troubles de la prostate |
AU2006311433B2 (en) * | 2005-11-08 | 2012-06-28 | Choongwae Pharma Corporation | Alpha-helix mimetics and method relating to the treatment of cancer stem cells |
WO2007100895A2 (fr) * | 2006-02-27 | 2007-09-07 | The Johns Hopkins University | Traitement anticancéreux utilisant des inhibiteurs de gamma-sécrétases |
WO2008013966A2 (fr) * | 2006-07-28 | 2008-01-31 | Johns Hopkins University | Utilisation de 8-quinolinol et de ses analogues pour cibler des cellules souches cancéreuses |
-
2007
- 2007-09-07 EP EP20140169091 patent/EP2783700A1/fr not_active Withdrawn
- 2007-09-07 US US11/900,029 patent/US20080118518A1/en not_active Abandoned
- 2007-09-07 CA CA2698583A patent/CA2698583A1/fr not_active Abandoned
- 2007-09-07 EP EP07837839A patent/EP2081590A4/fr not_active Ceased
- 2007-09-07 WO PCT/US2007/019480 patent/WO2008030538A2/fr active Application Filing
-
2015
- 2015-03-04 HK HK15102215.8A patent/HK1201724A1/xx unknown
-
2017
- 2017-06-12 US US15/619,827 patent/US20170274058A1/en not_active Abandoned
-
2019
- 2019-11-25 US US16/695,069 patent/US20200330566A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2698583A1 (fr) | 2008-03-13 |
WO2008030538A3 (fr) | 2008-11-13 |
EP2081590A4 (fr) | 2011-12-28 |
US20170274058A1 (en) | 2017-09-28 |
EP2081590A2 (fr) | 2009-07-29 |
WO2008030538A2 (fr) | 2008-03-13 |
US20080118518A1 (en) | 2008-05-22 |
EP2783700A1 (fr) | 2014-10-01 |
US20200330566A1 (en) | 2020-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1201724A1 (en) | Cancer stem cell-targeted cancer therapy | |
HRP20181385T1 (hr) | Ciljanje abcb5 za terapiju raka | |
ZA200807934B (en) | Cancer treatments | |
IL196559A0 (en) | Combination therapy | |
GB0614947D0 (en) | Epitope reduction therapy | |
ZA201004403B (en) | Therapeutic cancer treatments | |
IL196556A0 (en) | Combination therapy | |
IL199992A0 (en) | Combination therapy | |
EP2054061A4 (fr) | Thérapie par combinaison | |
GB0719518D0 (en) | Therapy | |
ZA200902203B (en) | Combination therapy | |
EP2211863A4 (fr) | Polythérapie | |
GB0700284D0 (en) | Combination therapy | |
HK1132911A1 (en) | Cancer vaccine | |
GB0606660D0 (en) | Targeted Therapy | |
GB0710871D0 (en) | Cancer treatment | |
GB0716072D0 (en) | Therapy | |
GB0700635D0 (en) | Therapy | |
GB0612259D0 (en) | Cancer therapeutic | |
GB0606702D0 (en) | Cancer therapeutic | |
GB0604741D0 (en) | Cancer Treatment | |
GB0618199D0 (en) | Cancer treatment | |
GB0706538D0 (en) | Cancer therapeutic | |
GB0603430D0 (en) | Therapy | |
GB0615039D0 (en) | Therapy |